Project Grant R01DK146932
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $754,682 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026 through April 30, 2030. This research initiative addresses beta cell dysfunction in Type 1 Diabetes (T1D) by investigating the metabolic and immunological mechanisms...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Miami's Office of Research Administration within the School of Medicine a Project Grant of $715,188 on February 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research initiative, titled "The Critical Role of Endothelial Inflammation in Arteriovenous Fistula Failure," focuses on...
- Federal Grant Award Summary The University of Michigan, Office of Research and Sponsored Projects, received a Project Grant of $129,306 awarded December 9, 2025, by the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research activities through June 30, 2028, to be conducted at the University of Michigan's Ann Arbor, Michigan campus. The funded research defines a...
- Federal Grant Award Summary The University of Michigan received a $785,969 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 6, 2026, with completion targeted for December 31, 2030. The research project investigates secretory pathway protein degradation mechanisms essential to insulin biogenesis and secretion in pancreatic beta cells. The...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of California, Irvine a Project Grant totaling $1,411,634 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of July 21, 2025 and completion date of April 30, 2029. The research addresses differential spatial cyclic adenosine monophosphate (cAMP) signaling in pancreatic beta cells, investigating how...
- Federal Grant Award Summary Tufts University School of Medicine received a $735,358 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded May 21, 2026, with completion targeted for February 28, 2030. This research grant funds investigator-initiated basic biomedical research focused on understanding enteroendocrine cell (EEC) dysfunction in obesity and...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $786,216 Project Grant to the University of California, Los Angeles (UCLA) on August 28, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a four-year research initiative (through June 30, 2029) investigating post-transcriptional regulation of hepatokines and systemic metabolism. The research focuses on identifying...
- Federal Project Grant Award Summary Pennington Biomedical Research Center received a $769,097 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 5, 2025, with completion scheduled for July 31, 2029. The grant supports fundamental neuroscience research investigating a novel brain-to-pancreatic islet neural circuit that regulates glucose...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Nevada, Reno a $2.56 million Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 15, 2025, with a completion date of September 14, 2029. This research award funds a four-year investigative project examining novel regulatory targets for gastrointestinal hormones and neuropeptides in...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $672,737 Project Grant to the University of California, Los Angeles (UCLA) on August 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research will be conducted through July 31, 2030, at UCLA's Los Angeles campus. This award supports basic biomedical research investigating the molecular mechanisms by which...
The University of Miami's Office of Research Administration in the School of Medicine received a $537,250 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded June 1, 2026, with a completion date of March 31, 2029. This award funds fundamental biomedical research investigating the neuronal entero-pancreatic circuit's role in glucose metabolism and beta cell function. The research aims to elucidate how sensory signals from the gastrointestinal tract are transmitted to pancreatic islets via enteric nerves to enable anticipatory glucose regulation, potentially identifying mechanisms comparable to hormonal incretins in controlling insulin secretion. The primary deliverables under this grant include scientific research outputs addressing three specific research aims: uncovering the mechanisms coupling gut sensing to entero-pancreatic neurons, elucidating neuronal signaling pathways between the gut and pancreas, and determining the physiological impact of the entero-pancreatic reflex on glucose metabolism. The research is designed to advance fundamental knowledge of beta cell function and inform development of novel therapeutic interventions for diabetes and metabolic disorders, consistent with NIDDK's mission to support basic and clinical biomedical research that improves understanding and treatment of diabetes and related metabolic diseases.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $537.3k | 6/3/26 |